7,573.40

+32.00

+0.42%

51,815.23

-168.75

-0.32%

25,383.56

+219.19

+0.87%

2,826.06

+20.19

+0.72%

4.9500

+0.0560

+1.14%

20.53

-0.62

-2.93%

3,935.00

-34.60

-0.87%

77,467.76

+516.29

+0.67%

Crude Oil Dec 26

95.98

-0.48

-0.50%

US Private Equity

10,836.30

-14.33

-0.13%

OTC Markets OTCPK - Delayed Quote USD

Santen Pharmaceutical Co., Ltd. (SNPHY)

11.82 +1.04 (+9.65%)

As of October 30 at 4:00:00 PM EDT. Market Open.

Santen Pharmaceutical (TSE:4536) Stock Could Be Undervalued On Current Earnings

Simply Wall St. 15d ago

4536.T

4536.TW
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability

GlobeNewswire 1mo ago

SGP

4536.T

BLCO
Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million

GlobeNewswire 1mo ago

LGND

4536.T
RVL Pharmaceuticals Announces Santen Obtains Manufacturing and Marketing Approval in Japan for UPNEEQ® Mini Ophthalmic Solution 0.1%

PR Newswire 9mo ago

SNPHF

RVLPQ

Mobilize your Website

View Site in Mobile | Classic

Share by: